{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:14:23Z","timestamp":1782461663387,"version":"3.54.5"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>The effect of changes in immunosuppressive therapy during the acute phase post-heart transplantation (HTx) on clinical outcomes remains unclear. This study aimed to investigate the effects of changes in immunosuppressive therapy by corticosteroid (CS) weaning and everolimus (EVR) initiation during the first year post-HTx on clinical outcomes. We analyzed 622 recipients registered in the Korean Organ Transplant Registry (KOTRY) between January 2014 and December 2021. The median age at HTx was 56\u00a0years (interquartile range [IQR], 45\u201362), and the median follow-up time was 3.9\u00a0years (IQR 2.0\u20135.1). The early EVR initiation within the first year post-HTx and maintenance during the follow-up is associated with reduced the risk of primary composite outcome (all-cause mortality or re-transplantation) (HR, 0.24; 95% CI 0.09\u20130.68; <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and cardiac allograft vasculopathy (CAV) (HR, 0.39; 95% CI 0.19\u20130.79; <jats:italic>p<\/jats:italic> = 0.009) compared with EVR-free or EVR intermittent treatment regimen, regardless of CS weaning. However, the early EVR initiation tends to increase the risk of acute allograft rejection compared with EVR-free or EVR intermittent treatment.<\/jats:p>","DOI":"10.3389\/ti.2024.11878","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:13:30Z","timestamp":1712333610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Everolimus Initiation and Corticosteroid Weaning During Acute Phase After Heart Transplantation on Clinical Outcome: Data from the Korean Organ Transplant Registry (KOTRY)"],"prefix":"10.3389","volume":"37","author":[{"given":"Kyu-Sun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungseop","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Oh","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jai","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th Official Adult Heart Transplant Report--2012","volume":"31","author":"Stehlik","year":"2012","journal-title":"J Heart Lung Transpl"},{"key":"B2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/tri.12309","article-title":"Steroid-Free and Steroid Withdrawal Protocols in Heart Transplantation: The Review of Literature","volume":"27","author":"Baraldo","year":"2014","journal-title":"Transpl Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4070\/kcj.2018.0189","article-title":"The Past, Present and Future of Heart Transplantation","volume":"48","author":"Kim","year":"2018","journal-title":"Korean Circ J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","article-title":"Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-Of-The-Art Review","volume":"137","author":"Stehlik","year":"2018","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/B978-1-4557-0268-8.00097-X","article-title":"Long-Term Toxicity of Immunosuppressive Therapy","volume-title":"Transplantation of the Liver (3","author":"Ruiz","year":"2015"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1161\/01.CIR.0000150332.42276.69","article-title":"Drug Therapy in the Heart Transplant Recipient: Part II: Immunosuppressive Drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1111\/tri.14142","article-title":"Steroid Withdrawal After Heart Transplantation in Adults","volume":"34","author":"Heegaard","year":"2021","journal-title":"Transpl Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.36628\/ijhf.2020.0034","article-title":"Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center","volume":"3","author":"Chang","year":"2021","journal-title":"Int J Heart Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.110.958520","article-title":"A Prospective, Randomized Trial of Single-Drug Versus Dual-Drug Immunosuppression in Heart Transplantation: The Tacrolimus in Combination, Tacrolimus Alone Compared (TICTAC) Trial","volume":"4","author":"Baran","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15361","article-title":"Comparing Everolimus-Based Immunosuppression With Reduction or Withdrawal of Calcineurin Inhibitor Reduction From Six Months After Heart Transplantation: The Randomized MANDELA Study","volume":"18","author":"Barten","year":"2019","journal-title":"Am J Transpl"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e004050","DOI":"10.1161\/CIRCHEARTFAILURE.117.004050","article-title":"Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","article-title":"Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients","volume":"71","author":"Asleh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/TP.0000000000001945","article-title":"Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART","volume":"102","author":"Potena","year":"2018","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1097\/TP.0000000000001432","article-title":"Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation","volume":"100","author":"Fine","year":"2016","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1097\/TP.0000000000001706","article-title":"Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation","volume":"101","author":"Nelson","year":"2017","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1097\/TXD.0000000000000678","article-title":"Design and Methods of the Korean Organ Transplantation Registry","volume":"3","author":"Yang","year":"2017","journal-title":"Transpl Direct"},{"key":"B17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4070\/kcj.2016.0403","article-title":"Initial Report of the Korean Organ Transplant Registry (KOTRY): Heart Transplantation","volume":"47","author":"Lee","year":"2017","journal-title":"Korean Circ J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.4070\/kcj.2018.0392","article-title":"The Korean Organ Transplant Registry (KOTRY): Second Official Adult Heart Transplant Report","volume":"49","author":"Kim","year":"2019","journal-title":"Korean Circ J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation Working Formulation of a Standardized Nomenclature for Cardiac Allograft Vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) Guidelines for the Care of Heart Transplant Recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 International Society for Heart and Lung Transplantation Working Formulation for the Standardization of Nomenclature in the Pathologic Diagnosis of Antibody-Mediated Rejection in Heart Transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transpl"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/s0041-1345(99)00446-7","article-title":"Study of Early Corticosteroid Withdrawal in Cardiac Transplantation","volume":"31","author":"Delgado","year":"1999","journal-title":"Transpl Proc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1161\/01.cir.96.6.2069","article-title":"Cardiac Allograft Vasculopathy: A Review","volume":"96","author":"Weis","year":"1997","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/01.TP.0000071200.37399.1D","article-title":"Diagnostic Accuracy of Coronary Angiography and Risk Factors for Post-Heart-Transplant Cardiac Allograft Vasculopathy","volume":"76","author":"Sharples","year":"2003","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.repc.2019.10.007","article-title":"Cardiac Allograft Vasculopathy: Incidence and Predictors in a Single-Center Cohort","volume":"39","author":"Pic\u00e3o","year":"2020","journal-title":"Rev Port Cardiol Engl Ed"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.11878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:13:34Z","timestamp":1712333614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.11878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":27,"alternative-id":["10.3389\/ti.2024.11878"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.11878","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"article-number":"11878"}}